Consensus on the treatment of vitiligo – Brazilian Society of Dermatology | Zendy

Gerson Dellatorre | Zendy; Daniela Alves Pereira Antelo | Zendy; Roberta Buense Bedrikow | Zendy; Tânia Ferreira Cestari | Zendy; Ivonise Follador | Zendy; Daniel Gontijo Ramos | Zendy; Caio César Silva de Castro | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Consensus on the treatment of vitiligo – Brazilian Society of Dermatology

Author(s) -

Gerson Dellatorre,

Daniela Alves Pereira Antelo,

Roberta Buense Bedrikow,

Tânia Ferreira Cestari,

Ivonise Follador,

Daniel Gontijo Ramos,

Caio César Silva de Castro

Publication year - 2020

Publication title -

anais brasileiros de dermatologia

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.461

H-Index - 44

eISSN - 1806-4841

pISSN - 0365-0596

DOI - 10.1016/j.abd.2020.05.007

Subject(s) - vitiligo , medicine , dermatology , disease , treatment modality , quality of life (healthcare) , surgery , pathology , nursing

Vitiligo is a muco-cutaneous, autoimmune, localized, or disseminated disease, which manifests through hypochromic or achromic macules, with loss in quality of life. The prevalence of vitiligo in Brazil was determined to be 0.54%. There is no on-label medication for its treatment. To date, no Brazilian consensus on the treatment of vitiligo had been written.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research